USD
+$0.00
(+0.00%
)At Close (As of Sep 12, 2025)
-
Market Cap
-
P/E Ratio
-
EPS
$47.36
52 Week High
$0.85
52 Week Low
HEALTHCARE
Sector
Field | Value (USD) |
---|---|
Gross Profit | -$3.9M |
Total Revenue | $57K |
Cost Of Revenue | $3.9M |
Costof Goods And Services Sold | $3.9M |
Operating Income | -$49M |
Selling General And Administrative | $14M |
Research And Development | $14M |
Operating Expenses | $45M |
Investment Income Net | - |
Net Interest Income | -$2.2M |
Interest Income | $254K |
Interest Expense | $2.5M |
Non Interest Income | - |
Other Non Operating Income | - |
Depreciation | - |
Depreciation And Amortization | $1.1M |
Income Before Tax | -$50M |
Income Tax Expense | - |
Interest And Debt Expense | - |
Net Income From Continuing Operations | -$50M |
Comprehensive Income Net Of Tax | - |
Ebit | -$47M |
Ebitda | -$46M |
Net Income | -$50M |
Field | Value (USD) |
---|---|
Total Assets | $3.7M |
Total Current Assets | $2.8M |
Cash And Cash Equivalents At Carrying Value | $2.1M |
Cash And Short Term Investments | $2.1M |
Inventory | $0 |
Current Net Receivables | $314K |
Total Non Current Assets | $901K |
Property Plant Equipment | - |
Accumulated Depreciation Amortization Ppe | - |
Intangible Assets | - |
Intangible Assets Excluding Goodwill | - |
Goodwill | - |
Investments | - |
Long Term Investments | - |
Short Term Investments | - |
Other Current Assets | $332K |
Other Non Current Assets | - |
Total Liabilities | $17M |
Total Current Liabilities | $16M |
Current Accounts Payable | $2.2M |
Deferred Revenue | - |
Current Debt | - |
Short Term Debt | $11M |
Total Non Current Liabilities | $718K |
Capital Lease Obligations | $1.3M |
Long Term Debt | - |
Current Long Term Debt | $9.9M |
Long Term Debt Noncurrent | - |
Short Long Term Debt Total | $11M |
Other Current Liabilities | $3.3M |
Other Non Current Liabilities | - |
Total Shareholder Equity | -$13M |
Treasury Stock | - |
Retained Earnings | -$195M |
Common Stock | $151 |
Common Stock Shares Outstanding | $833K |
Field | Value (USD) |
---|---|
Operating Cashflow | -$30M |
Payments For Operating Activities | - |
Proceeds From Operating Activities | - |
Change In Operating Liabilities | - |
Change In Operating Assets | - |
Depreciation Depletion And Amortization | $1.1M |
Capital Expenditures | $161K |
Change In Receivables | - |
Change In Inventory | $0 |
Profit Loss | - |
Cashflow From Investment | -$161K |
Cashflow From Financing | $18M |
Proceeds From Repayments Of Short Term Debt | - |
Payments For Repurchase Of Common Stock | - |
Payments For Repurchase Of Equity | - |
Payments For Repurchase Of Preferred Stock | - |
Dividend Payout | - |
Dividend Payout Common Stock | - |
Dividend Payout Preferred Stock | - |
Proceeds From Issuance Of Common Stock | - |
Proceeds From Issuance Of Long Term Debt And Capital Securities Net | - |
Proceeds From Issuance Of Preferred Stock | - |
Proceeds From Repurchase Of Equity | - |
Proceeds From Sale Of Treasury Stock | - |
Change In Cash And Cash Equivalents | - |
Change In Exchange Rate | - |
Net Income | -$50M |
Field | Value (USD) |
---|---|
Gross Profit | -$3.9M |
Total Revenue | $57K |
Cost Of Revenue | $3.9M |
Costof Goods And Services Sold | $3.9M |
Operating Income | -$49M |
Selling General And Administrative | $14M |
Research And Development | $14M |
Operating Expenses | $45M |
Investment Income Net | - |
Net Interest Income | -$2.2M |
Interest Income | $254K |
Interest Expense | $2.5M |
Non Interest Income | - |
Other Non Operating Income | - |
Depreciation | - |
Depreciation And Amortization | $1.1M |
Income Before Tax | -$50M |
Income Tax Expense | - |
Interest And Debt Expense | - |
Net Income From Continuing Operations | -$50M |
Comprehensive Income Net Of Tax | - |
Ebit | -$47M |
Ebitda | -$46M |
Net Income | -$50M |
Sector: HEALTHCARE
Industry: BIOTECHNOLOGY
Hyperion DeFi, Inc., an ophthalmic technology company, engages in development and commercialization of ophthalmic solutions in the United States. The company is headquartered in New York, New York.